Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer

Oncotarget. 2021 Oct 12;12(21):2232-2233. doi: 10.18632/oncotarget.28096. eCollection 2021 Oct 12.ABSTRACT[This corrects the article DOI: 10.18632/oncotarget.25952.].PMID:34676057 | PMC:PMC8522840 | DOI:10.18632/oncotarget.28096
Source: Oncotarget - Category: Cancer & Oncology Authors: Source Type: research